These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2068294)

  • 41. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
    Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbohydrate antigens and liver metastasis in colorectal cancer.
    Hasegawa H; Watanabe M; Arisawa Y; Teramoto T; Kodaira S; Kitajima M
    Jpn J Clin Oncol; 1993 Dec; 23(6):336-41. PubMed ID: 7904324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rim enhancement in colorectal metastases at CT during infusion hepatic arteriography. Does it represent liver parenchyma or live tumor cell zone?
    Irie T; Tsushima Y; Terahata S; Hatsuse K; Kusano S
    Acta Radiol; 1997 May; 38(3):416-21. PubMed ID: 9191433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First histologic findings in metastases of colorectal carcinoma following isolated liver perfusion with cytostatics.
    Schulz A; Kracht J
    Recent Results Cancer Res; 1983; 86():283-8. PubMed ID: 6648010
    [No Abstract]   [Full Text] [Related]  

  • 49. No treatment option for liver metastases from colorectal adenocarcinoma.
    Palmer M; Petrelli NJ; Herrera L
    Dis Colon Rectum; 1989 Aug; 32(8):698-701. PubMed ID: 2752858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progressive CT appearance of hepatic metastases from colorectal carcinoma.
    Letourneau JG; Thompson WM; Goldberg ME; Snover DC; Grage TB; Frick MP
    Gastrointest Radiol; 1988; 13(2):145-51. PubMed ID: 3360247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal tumors: an in vitro study of high-resolution MR imaging.
    Imai Y; Kressel HY; Saul SH; Chao PW; Schnall MD; Lenkinski RE; Listerud JM; Daly JM
    Radiology; 1990 Dec; 177(3):695-701. PubMed ID: 2243971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histopathological correlation of ultrasound appearances of liver metastases.
    Viscomi GN; Gonzalez R; Taylor KJ
    J Clin Gastroenterol; 1981 Dec; 3(4):395-400. PubMed ID: 7338621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic metastases: basic principles and implications for radiologists.
    Baker ME; Pelley R
    Radiology; 1995 Nov; 197(2):329-37. PubMed ID: 7480672
    [No Abstract]   [Full Text] [Related]  

  • 54. Quantitation of total metastatic tumor volume in the rat liver: correlation of MR and histologic measurements.
    Mahmood U; Devitt ML; Kocheril PG; Sutanto-Ward E; Ballon D; Sigurdson ER; Koutcher JA
    J Magn Reson Imaging; 1992; 2(3):335-40. PubMed ID: 1627869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contact ultrasonography in the detection of liver metastases from colorectal cancer: an in vitro study.
    Thomas WM; Morris DL; Hardcastle JD
    Br J Surg; 1987 Oct; 74(10):955-6. PubMed ID: 3311280
    [No Abstract]   [Full Text] [Related]  

  • 56. Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors: an in vitro correlative study.
    Wernecke K; Henke L; Vassallo P; von Bassewitz DB; Diederich S; Peters PE; Edel G
    AJR Am J Roentgenol; 1992 Nov; 159(5):1011-6. PubMed ID: 1329455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 9.4-T NMR microimaging studies of hepatic metastases of human colorectal tumors in nude mice.
    Sarkar SK; Clark RK; Rycyna RE; Mattingly MA; Greig R
    Magn Reson Med; 1989 Nov; 12(2):268-73. PubMed ID: 2615633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gaining insight: improved images enhance understanding.
    Seltzer SE; Judy PF
    Radiographics; 1987 Nov; 7(6):1221-40. PubMed ID: 3423329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic mesenchymal sarcoma: MRI findings.
    Martí-Bonmatí L; Ferrer D; Menor F; Galant J
    Abdom Imaging; 1993; 18(2):176-9. PubMed ID: 8439759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic metastases in medullary thyroid carcinoma: possible pitfall with MR imaging.
    Van Beers B; Pringot J; Defalque D
    Eur J Radiol; 1990; 11(2):107-9. PubMed ID: 2253630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.